Showing results (1-10 of 283) with videos related to
Sort By:
Pageof 29
The Journal of Nervous and Mental Disease|December 1, 1982
The DSM-III diagnosis of schizophrenic-like illness and the clinical pharmacology of psychosisC A Tamminga, W T CarpenterThe American Journal of Psychiatry|September 1, 1997
Time to clozapine response in a standardized trialR R Conley, W T Carpenter, C A TammingaThe American Journal of Psychiatry|June 1, 1995
Patient response and resource management: another view of clozapine treatment of schizophreniaW T Carpenter, R R Conley, R W Buchanan, et al.Biological Psychiatry|December 1, 1992
Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatientsB Kirkpatrick, W T Carpenter, K Maeda, et al.Biological Psychiatry|June 1, 1989
Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptationB Kirkpatrick, R W Buchanan, K Maeda, et al.The American Journal of Psychiatry|November 3, 2001
Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition taskA C Lahti, H H Holcomb, D R Medoff, et al.Archives of General Psychiatry|July 1, 1992
Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndromeC A Tamminga, G K Thaker, R Buchanan, et al.CNS Spectrums|August 18, 2004
Treating schizophrenia now and developing strategies for the next decadeC A TammingaCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 1, 1997
The promise of new drugs for schizophrenia treatmentC A TammingaJournal of Neural Transmission (Vienna, Austria : 1996)|April 17, 2002
Partial dopamine agonists in the treatment of psychosisC A TammingaPageof 29